155 related articles for article (PubMed ID: 25784803)
1. Quantum dot-based multiplexed imaging in malignant ascites: a new model for malignant ascites classification.
Zeng WJ; Peng CW; Yuan JP; Cui R; Li Y
Int J Nanomedicine; 2015; 10():1759-68. PubMed ID: 25784803
[TBL] [Abstract][Full Text] [Related]
2. Lysyl oxidase activates cancer stromal cells and promotes gastric cancer progression: quantum dot-based identification of biomarkers in cancer stromal cells.
Peng C; Liu J; Yang G; Li Y
Int J Nanomedicine; 2018; 13():161-174. PubMed ID: 29343955
[TBL] [Abstract][Full Text] [Related]
3. Patients' perspectives towards malignant ascites: results of a prospective observational trial regarding expectations, characteristics and quality of life-a study of the North-Eastern-German Society of Gynecological Oncology.
Armbrust R; Neeb C; Thuss-Patience P; Lüftner D; Pietzner K; Riess H; Oskay-Öczelik G; Richter R; Keller M; Sehouli J
Arch Gynecol Obstet; 2019 May; 299(5):1385-1389. PubMed ID: 30834969
[TBL] [Abstract][Full Text] [Related]
4. Tumor invasion unit in gastric cancer revealed by QDs-based in situ molecular imaging and multispectral analysis.
Hu WQ; Fang M; Zhao HL; Yan SG; Yuan JP; Peng CW; Yang GF; Li Y; Li JD
Biomaterials; 2014 Apr; 35(13):4125-32. PubMed ID: 24529897
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic cancer with malignant ascites: clinical features and outcomes.
Takahara N; Isayama H; Nakai Y; Sasaki T; Saito K; Hamada T; Mizuno S; Miyabayashi K; Mohri D; Kogure H; Matsubara S; Yamamoto N; Hirano K; Ijichi H; Tateishi K; Tada M; Koike K
Pancreas; 2015 Apr; 44(3):380-5. PubMed ID: 25636085
[TBL] [Abstract][Full Text] [Related]
6. A fluorescent polymeric quantum dot/aptamer superstructure and its application for imaging of cancer cells.
Jie G; Zhao Y; Qin Y
Chem Asian J; 2014 May; 9(5):1261-4. PubMed ID: 24616365
[TBL] [Abstract][Full Text] [Related]
7. Patterns of cancer invasion revealed by QDs-based quantitative multiplexed imaging of tumor microenvironment.
Peng CW; Liu XL; Chen C; Liu X; Yang XQ; Pang DW; Zhu XB; Li Y
Biomaterials; 2011 Apr; 32(11):2907-17. PubMed ID: 21262536
[TBL] [Abstract][Full Text] [Related]
8. Quantitative detection of the tumor-associated antigen large external antigen in colorectal cancer tissues and cells using quantum dot probe.
Wang S; Li W; Yuan D; Song J; Fang J
Int J Nanomedicine; 2016; 11():235-47. PubMed ID: 26834472
[TBL] [Abstract][Full Text] [Related]
9. Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites.
Lim B; Kim C; Kim JH; Kwon WS; Lee WS; Kim JM; Park JY; Kim HS; Park KH; Kim TS; Park JL; Chung HC; Rha SY; Kim SY
Oncotarget; 2016 Feb; 7(7):8055-66. PubMed ID: 26811494
[TBL] [Abstract][Full Text] [Related]
10. Malignant ascites-derived organoid (MADO) cultures for gastric cancer in vitro modelling and drug screening.
Li J; Xu H; Zhang L; Song L; Feng D; Peng X; Wu M; Zou Y; Wang B; Zhan L; Hua G; Zhan X
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2637-2647. PubMed ID: 31598791
[TBL] [Abstract][Full Text] [Related]
11. A survey of treatment approaches of malignant ascites in Germany and Austria.
Jehn CF; Küpferling S; Oskay-Özcelik G; Lüftner D
Support Care Cancer; 2015 Jul; 23(7):2073-8. PubMed ID: 25528551
[TBL] [Abstract][Full Text] [Related]
12. Quantum dot-based immunofluorescent imaging and quantitative detection of TOP2A and prognostic value in triple-negative breast cancer.
Zheng H; Li X; Chen C; Chen J; Sun J; Sun S; Jin L; Li J; Sun S; Wu X
Int J Nanomedicine; 2016; 11():5519-5529. PubMed ID: 27799773
[TBL] [Abstract][Full Text] [Related]
13. Quantum dot-based in situ simultaneous molecular imaging and quantitative analysis of EGFR and collagen IV and identification of their prognostic value in triple-negative breast cancer.
Zheng HM; Chen C; Wu XH; Chen J; Sun S; Sun JZ; Wang MW; Sun SR
Tumour Biol; 2016 Feb; 37(2):2509-18. PubMed ID: 26385773
[TBL] [Abstract][Full Text] [Related]
14. Outpatient Intraperitoneal Catumaxomab Therapy for Malignant Ascites Related to Advanced Gynecologic Neoplasms.
Kurbacher CM; Horn O; Kurbacher JA; Herz S; Kurbacher AT; Hildenbrand R; Bollmann R
Oncologist; 2015 Nov; 20(11):1333-41. PubMed ID: 26417039
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stem Cells Engineered to Secrete Pigment Epithelium-Derived Factor Inhibit Tumor Metastasis and the Formation of Malignant Ascites in a Murine Colorectal Peritoneal Carcinomatosis Model.
Yang L; Zhang Y; Cheng L; Yue D; Ma J; Zhao D; Hou X; Xiang R; Cheng P
Hum Gene Ther; 2016 Mar; 27(3):267-77. PubMed ID: 26756933
[TBL] [Abstract][Full Text] [Related]
16. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.
Yamaguchi Y; Ohshita A; Kawabuchi Y; Hihara J; Miyahara E; Noma K; Toge T
Int J Oncol; 2004 Apr; 24(4):959-66. PubMed ID: 15010836
[TBL] [Abstract][Full Text] [Related]
17. The role of "closed abdomen" hyperthermic intraperitoneal chemotherapy (HIPEC) in the palliative treatment of neoplastic ascites from peritoneal carcinomatosis: report of a single-center experience.
Orgiano L; Pani F; Astara G; Madeddu C; Marini S; Manca A; Mantovani G
Support Care Cancer; 2016 Oct; 24(10):4293-9. PubMed ID: 27169699
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer.
Facchiano E; Scaringi S; Kianmanesh R; Sabate JM; Castel B; Flamant Y; Coffin B; Msika S
Eur J Surg Oncol; 2008 Feb; 34(2):154-8. PubMed ID: 17640844
[TBL] [Abstract][Full Text] [Related]
19. Biomarker quantification by multiplexed quantum dot technology for predicting lymph node metastasis and prognosis in head and neck cancer.
Hu Z; Qian G; Müller S; Xu J; Saba NF; Kim S; Chen Z; Jiang N; Wang D; Zhang H; Lane K; Hoyt C; Shin DM; Chen ZG
Oncotarget; 2016 Jul; 7(28):44676-44685. PubMed ID: 27172790
[TBL] [Abstract][Full Text] [Related]
20. The complex role of IL-10 in malignant ascites: a review.
Huang Y; Zou K; Jiang H; Li Z
Cancer Immunol Immunother; 2024 Jan; 73(2):32. PubMed ID: 38279997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
